Chasing the dragon - characterizing cases of leukoencephalopathy associated with heroin inhalation in British Columbia.
An association between leukoencephalopathy, a disease of the white matter of the brain, and smoking heroin is well recognized. This paper describes 27 cases of leukoencephalopathy identified in two cities in British Columbia, Canada 2001-2006; the largest number of geographically and temporally defined reported cases in North America.Twenty cases of leukoencephalopathy were identified in and around Vancouver with onset dates December 2001 to July 2003; seven further cases were identified in Victoria September 2005-August 2006. Twenty (74%) of all cases were male, two couples were reported and eleven cases (55%) had Asian ethnicity. One case reported smoking heroin on a single occasion and developed mild symptoms; all other cases were hospitalized. Thirteen (48%) cases died; all had smoked heroin for a minimum of 3 years. Testing of one available heroin sample identified no substance other than common cutting agents.Although a specific etiology was not identified our study supports the theory of an intermittent exposure to a toxic agent added to the heroin or a combustion by-product. It also suggests a dose response effect rather than genetic predisposition. Collaboration with public health, health professionals, law enforcement and persons who use illegal drugs, will facilitate the early identification of cases to enable timely and complete follow-up including obtaining samples. Testing of implicated heroin samples may allow identification of the contaminant and therefore prevent further cases. It is therefore important to ensure key stakeholders are aware of our findings.
Epidemiology Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada. jane.buxton@bccdc.ca.
Jane A
JA
Buxton
Renee
R
Sebastian
Lorne
L
Clearsky
Natalie
N
Angus
Lena
L
Shah
Marcus
M
Lem
Sian D
SD
Spacey
N Engl J Med. 1997 Feb 20;336(8):589-90
9036319
Chin Med J (Engl). 2001 Nov;114(11):1193-5
11729518
J Neurol Neurosurg Psychiatry. 1996 Jun;60(6):694-5
8648344
Intensive Care Med. 2003 Jun;29(6):1012-1015
12637976
Neurology. 2005 May 24;64(10):1755
15911804
J Toxicol Clin Toxicol. 2003;41(6):887-91
14677803
J Neurol. 1999 Sep;246(9):850-1
10525989
J Comput Assist Tomogr. 2000 Sep-Oct;24(5):735-7
11045695
Di Yi Jun Yi Da Xue Xue Bao. 2003 Feb;23(2):172-4
12581974
Zhonghua Nei Ke Za Zhi. 2001 Nov;40(11):753-6
11930682
Di Yi Jun Yi Da Xue Xue Bao. 2002 Jul;22(7):659-60
12376308
Neuropediatrics. 2003 Apr;34(2):100-4
12776233
N Engl J Med. 2001 Aug 9;345(6):425-32
11496854
J Formos Med Assoc. 1997 Sep;96(9):758-60
9308333
Australas Radiol. 2002 Sep;46(3):306-8
12196243
J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):1014-6
15965216
J Forensic Sci. 2002 Jul;47(4):885-8
12137001
AJR Am J Roentgenol. 2003 Mar;180(3):847-50
12591709
Ned Tijdschr Geneeskd. 1982 Jan 16;126(3):111-2
7057937
Pharm Weekbl Sci. 1987 Aug 21;9(4):203-11
3658647
Lancet. 1992 Sep 19;340(8821):729
1355826
Acta Neuropathol. 1997 Jul;94(1):87-90
9224535
CMAJ. 2000 Jan 25;162(2):236-8
10674060
Neurology. 1999 Nov 10;53(8):1765-73
10563626
Addiction. 2009 May;104(5):798-805
19413792
Br J Addict. 1988 Oct;83(10):1159-62
3191264
J Clin Neurosci. 2001 Mar;8(2):165-7
11243768
AJNR Am J Neuroradiol. 1994 Jan;15(1):175-8
8141052
Eur Radiol. 1998;8(5):749-55
9601960
Eur J Neurol. 2000 Nov;7(6):595-606
11136345